Skip to main content
EJNMMI Physics
Fig. 2 | EJNMMI Physics

Fig. 2

From: Towards personalised dosimetry in patients with liver malignancy treated with 90Y-SIRT using in vivo-driven radiobiological parameters

Fig. 2

Progressive metabolic disease (PMD) for a patient with metastatic CRC liver malignancy. Deformable PET images and corresponding calculated voxel SF and TCP. a The deformably registered pre- and post-treatment [18F] FDG PET images. b, c The estimated voxel SF and TCP. The survival fraction and TCP were calculated based on the 90Y absorbed dose and SUV volume histograms. The radiobiological parameters were derived from the GLQ fit (see Table 1)

Back to article page